IN

Infinium Pharmachem LtdNSE INFINIUM Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.012

Micro

Exchange

XNSE - National Stock Exchange Of India

INFINIUM.NS Stock Analysis

IN

Uncovered

Infinium Pharmachem Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.012

Dividend yield

Shares outstanding

13.916 B

Infinium Pharmachem Ltd. manufactures and supplies iodine derivatives. The company is headquartered in Vallabh Vidyanagar, Gujarat. The company went IPO on 2023-04-17. The firm is involved in the development, manufacture, and export of a spectrum of the Iodine Derivatives that are used in pharmaceutical, chemical, biotech and allied industries across the globe. The firm's portfolio includes approximately 200+ Iodine Derivatives and seven+ APIs. The company manufactures and supplies a range of Iodine based APIs, but on Order to Made basis only. The company offers bulk actives, intermediates and services for custom synthesis. The company also provides contract Research and manufacturing Services to the pharmaceutical and biotech companies for their diverse requirements of Iodine based APIs and intermediates to reduce their research time and project cost. The company manufactures iodine derivatives for the various industries, including pharmaceutical, chemical, nutraceutical, cosmetics, sanitation, agrochemical, electronics, Nylon production and other industries for their range of industrial applications.

View Section: Eyestock Rating